Hint mode is switched on Switch off
For swift navigation between sections

Probi
LEI 5493004CJOCT273MU397

Organization name
Probi AB
Country name
Sweden
Country of registration
Sweden
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Probi AB is a research and development company that focuses on developing robust probiotics that withstand tough manufacturing processes and meet all the requirements of demanding customers. The three main areas of research include surgery and medicine, foodstuff technology, and microbiology. The company also develops animal feed. Its brands consist of two trademarks: Probi Digestis and Probi Defendum. Probi's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others.

Awards

Documentation

Stocks

Public debt by currencies

Codes

  • LEI
    5493004CJOCT273MU397
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Organisationsnummer
    556417-7540
Registration is required to get access.